Integrated Diagnostics Holdings plc (LON: IDHC)

Market Cap	183.75M
Revenue (ttm)	78.23M
Net Income (ttm)	13.46M
Shares Out	581.33M
EPS (ttm)	0.02
PE Ratio	13.95
Forward PE	14.13
Dividend	n/a
Ex-Dividend Date	n/a

Volume	223,818
Open	0.393
Previous Close	0.380
Day's Range	0.393 - 0.428
52-Week Range	0.275 - 0.540
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 15, 2024

About IDHC

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, including positron emission tomography – computed tomography (PET-CT), magnetic resonance imaging (MRI), computed tomography (CT), mammography, ultrasound, x-ray, electromyog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 6,692
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IDHC

Financial Performance

In 2023, IDHC's revenue was 4.12 billion, an increase of 14.35% compared to the previous year's 3.61 billion. Earnings were 510.30 million, a decrease of -5.69%.

Financial numbers in EGP